Table 2.

Multivariable logistic regression analysis for overall and organ-specific cGVHD response

Response toContrastMultivariable logistic
OR95% CIP
Overall response Years from transplant to study <2.5 vs ≥2.5 4.12 1.64-10.3 .0025 
No. of prior therapies <4 vs ≥4 5.29 1.83-15.3 .002 
Years from cGVHD to study <1.6 vs ≥1.6 4.60 1.79-11.8 .0015 
Skin Years from transplant to study <2.5 vs ≥2.5 3.80 1.38-10.4 .0096 
No. of prior therapies <4 vs ≥4 5.06 1.44-17.7 .011 
Years from cGVHD to study <1.6 vs ≥1.6 2.8 1.03-7.6 .044 
JMF No. of prior therapies <4 vs ≥4 2.63 0.86-8.02 .089 
Lung/GI tract/liver No. of prior therapies <4 vs ≥4 3.45 0.97-12.3 .056 
Response toContrastMultivariable logistic
OR95% CIP
Overall response Years from transplant to study <2.5 vs ≥2.5 4.12 1.64-10.3 .0025 
No. of prior therapies <4 vs ≥4 5.29 1.83-15.3 .002 
Years from cGVHD to study <1.6 vs ≥1.6 4.60 1.79-11.8 .0015 
Skin Years from transplant to study <2.5 vs ≥2.5 3.80 1.38-10.4 .0096 
No. of prior therapies <4 vs ≥4 5.06 1.44-17.7 .011 
Years from cGVHD to study <1.6 vs ≥1.6 2.8 1.03-7.6 .044 
JMF No. of prior therapies <4 vs ≥4 2.63 0.86-8.02 .089 
Lung/GI tract/liver No. of prior therapies <4 vs ≥4 3.45 0.97-12.3 .056 

or Create an Account

Close Modal
Close Modal